Evidence map›Paper›PMID 34357415›Full record

ArticlePediatric cardiology2022

On Left Ventricle Stroke Work Efficiency in Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis.

M Asaadi, W Mawad, A Djebbari, Z Keshavardz-Motamed, N Dahdah, L Kadem

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

M Asaadi *Laboratory of Cardiovascular Fluid Dynamics, Department of Mechanical Industrial and Aerospace Engineering, Concordia University, 1455 de Maisonneuve Blvd. W., Montreal, QC, H3G 1M8, Canada.
W Mawad *Division of Pediatric Cardiology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada.
A DjebbariDepartement of Biomedical Engineering, Faculty of Technology, University of Tlemcen, Tlemcen, Algeria.
Z Keshavardz-MotamedDepartment of Mechanical Engineering, McMaster University, Hamilton, ON, Canada.
N DahdahDivision of Pediatric Cardiology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada.
L KademLaboratory of Cardiovascular Fluid Dynamics, Department of Mechanical Industrial and Aerospace Engineering, Concordia University, 1455 de Maisonneuve Blvd. W., Montreal, QC, H3G 1M8, Canada. lcfd@encs.concordia.ca.
Centre Hospitalier Universitaire Sainte-Justine · CAConcordia University · CAMcGill University · CAMcMaster University · CAUniversity of Abou Bekr Belkaïd · DZ

Funding

NSERC 343164-07
6 · The paper itself

Abstract

The optimal timing for management of pediatric patients with moderate aortic valve disease [moderate aortic stenosis (modAS) or moderate aortic regurgitation (modAR)] remains unknown and largely unexplored. Although usually asymptomatic, the risk of increased left ventricular (LV) wall stress, irreversible myocardial fibrosis and sudden death in untreated moderate conditions warrants clearer risk stratification for appropriate timely intervention. In this study, we explore the use of a patient-specific mathematical model to introduce a new evaluative parameter of LV performance in patients with moderate aortic valve disease. Synthetic patient data (N = 520) representing healthy patients, and patients with modAS or modAR were first generated. Then, data from twenty-five pediatric patients were included in this study (healthy = 9; moderate AS = 8; modAR = 8). The effect of modAS or modAR on LV performance was evaluated by LV stroke work (LVSW) efficiency, a new non-invasive parameter. The results demonstrate that healthy patients possess a very high LVSW efficiency (synthetic data: 91 ± 2%, in vivo data: 92 ± 3%). However, modAS patients have a significant reduction in LVSW efficiency (synthetic data: 78 ± 2%, in vivo data: 76 ± 5%, p < 0.05), whereas modAR patients had the lowest LVSW efficiency (synthetic data: 58 ± 3%, in vivo data: 66 ± 7%; p < 0.05). This highlights that patients with moderate aortic valve disease require careful myocardial assessment, regardless of onset of clinical symptoms as their LV performance is significantly reduced. The evaluation of LVSW efficiency offers a promising avenue for future stratification of mixed aortic valve disease for optimal timing of management and intervention.

Indexed as

Aortic Valve InsufficiencyAortic Valve StenosisStrokeAortic ValveChildHeart VentriclesHumansStroke VolumeVentricular Function, LeftLeft ventricle energy performanceMathematical modelingModerate aortic regurgitationModerate aortic stenosisModerate aortic valve disease

Identifiers

PMID34357415
OpenAlexW3191259057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.